Literature DB >> 21726628

Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.

Yi-Cheng Lin1, Synthia H Sun, Fung-Fang Wang.   

Abstract

Polo-like kinase 1 (Plk1) plays key roles in many aspects of mitosis. We have previously shown that induction of p21(Waf1) by p53 is responsible for protection of cells against adriamycin-induced polyploidy formation and mitotic catastrophe. Here we show that adriamycin treatment suppressed Plk1 expression in a p53- and p21(Waf1)-dependent manner. Ablation of p21(Waf1) inhibited the adriamycin-induced p53 activation, and this inhibition was alleviated by knockdown of Plk1, suggesting that p21(Waf1)-dependent suppression of Plk1 expression is responsible for maintaining p53 activation during stress response. Plk1 associated with p53 and disrupted its interaction with target gene promoters in cells treated with adriamycin. Overexpression of Plk1 inhibited the p53-mediated prevention of caspase-independent mitotic death, but not polyploidy formation, in adriamycin-treated cells. Together our results indicate that suppression of Plk1 by p21(Waf1) is responsible for p53-dependent protection against adriamycin-induced caspase-independent mitotic death.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726628     DOI: 10.1016/j.cellsig.2011.06.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma.

Authors:  Weiwei Shan; Patricia Y Akinfenwa; Kari B Savannah; Nonna Kolomeyevskaya; Rudolfo Laucirica; Dafydd G Thomas; Kunle Odunsi; Chad J Creighton; Dina C Lev; Matthew L Anderson
Journal:  Clin Cancer Res       Date:  2012-04-25       Impact factor: 12.531

2.  Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.

Authors:  Brian D Cholewa; Mary A Ndiaye; Wei Huang; Xiaoqi Liu; Nihal Ahmad
Journal:  Cancer Lett       Date:  2016-10-25       Impact factor: 8.679

Review 3.  The role of polo-like kinase 1 in carcinogenesis: cause or consequence?

Authors:  Brian D Cholewa; Xiaoqi Liu; Nihal Ahmad
Journal:  Cancer Res       Date:  2013-11-21       Impact factor: 12.701

4.  Inhibition of Plk1 and Cyclin B1 expression results in panobinostat-induced G₂ delay and mitotic defects.

Authors:  Michael Prystowsky; Katherine Feeney; Nicole Kawachi; Cristina Montagna; Michelle Willmott; Christopher Wasson; Maciej Antkowiak; Olivier Loudig; Joanna Parish
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

5.  Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.

Authors:  Y-C Lin; Y-N Chen; K-F Lin; F-F Wang; T-Y Chou; M-Y Chen
Journal:  Cell Death Dis       Date:  2014-01-09       Impact factor: 8.469

6.  Synthetic curcumin derivative DK1 possessed G2/M arrest and induced apoptosis through accumulation of intracellular ROS in MCF-7 breast cancer cells.

Authors:  Norlaily Mohd Ali; Swee Keong Yeap; Nadiah Abu; Kian Lam Lim; Huynh Ky; Ahmad Zaim Mat Pauzi; Wan Yong Ho; Sheau Wei Tan; Han Kiat Alan-Ong; Seema Zareen; Noorjahan Banu Alitheen; M Nadeem Akhtar
Journal:  Cancer Cell Int       Date:  2017-02-21       Impact factor: 5.722

7.  Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells.

Authors:  Masahisa Kudo; Nicole Zalles; Rosario Distefano; Giovanni Nigita; Dario Veneziano; Pierluigi Gasparini; Carlo M Croce
Journal:  Cell Death Differ       Date:  2021-09-24       Impact factor: 12.067

Review 8.  Polo-like kinase-1 in DNA damage response.

Authors:  Sun-Yi Hyun; Hyo-In Hwang; Hyo-In Hwan; Young-Joo Jang
Journal:  BMB Rep       Date:  2014-05       Impact factor: 4.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.